Sleep Disorders Trial, Recruiting NCT06656533 Sponsor: Stanford University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06656533
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women of any racial or ethnic background, between the ages of 25 and 45 (inclusive)
  • People who have been diagnosed with insomnia through a specific structured interview called the DUKE
  • People who are fluent in English and able to read and write in English
  • People who are willing and able to provide written consent to participate
  • People who live within 60 miles of Stanford University

Who may not be able to join:

  • People who have other sleep or circadian rhythm disorders that are significantly contributing to their sleep problems, as assessed through the DUKE structured interview
  • People who regularly use benzodiazepines, opiates, thyroid medications, anticonvulsants, or antipsychotic medications
  • People who use psychiatric medications that significantly affect sleep or alertness, or who use illicit drugs
  • People who drink more than 14 alcoholic drinks per week, or more than 4 drinks on a single occasion
  • People who show signs of elevated suicide risk, as measured by a specific depression questionnaire (the Beck Depression Inventory)
  • People with a history of neurological or heart conditions, brain surgery, electroconvulsive or radiation treatment, brain bleeding or tumors, stroke, seizures or epilepsy, diabetes, thyroid disorders, or head trauma that caused loss of consciousness for more than 30 minutes
  • People with a history of substance abuse or dependence
  • People with a history of significant head trauma that led to lasting neurological problems, a known structural brain abnormality, or a traumatic brain injury within the past two months
  • People with serious difficulties with vision, hearing, or hand movement that would interfere with completing study tasks, or who are unlikely to be able to follow study procedures
  • People who are pregnant or breastfeeding
  • People with a current or lifetime history of bipolar disorder, PTSD, psychosis, or who are currently experiencing depression
  • People who have received cognitive behavioural therapy for insomnia within the past year
  • People who are currently experiencing trauma, or who have experienced trauma within the past 3 months
  • People who work rotating shifts that overlap with midnight (12:00 AM)
  • People who are identified as high risk for sleep apnea on the Berlin Questionnaire and are not consistently using CPAP therapy
  • People with a current psychiatric disorder who are also taking certain antidepressants known to increase seizure risk, specifically clomipramine, bupropion, or maprotiline

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 9512313891

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Insomnia Severity Index (ISI); Pittsburgh Sleep Quality Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov